VKTX

NASDAQ · Biotechnology

Viking Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$28.99

-0.37 (-1.26%)

As of Sep 20, 10:00 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 23 88%

Hold 3 12%

Sell 0 0%

Price Target

Analyst Price Target +135.3% upside

Low Target $46.84

Average Target $68.21

High Target $80.11

Current Price $28.99

Current
$28.99

Target
$68.21

$46.84 $68.21 avg $80.11

Scenario Analysis

Bear Case

$46.84

61.6%

Low target

Base Case

$68.21

+135.3%

Avg target

Bull Case

$80.11

+176.3%

High target

Risk/Reward

2.9x

Favorable

Price in Context

52-Week High

$43.15

-32.8% from high

52-Week Low

$22.96

+26.3% from low

50-Day SMA

$34.34

-15.6% vs SMA

200-Day SMA

$33.57

-13.6% vs SMA

RSI (14)

31.5

Neutral

Target vs 52W High

$68.21

+58.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.7%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.3%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.3%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.8%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.5%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-41.0%